ALX Oncology Holdings Inc. (ALXO) Tops Q3 EPS by 20c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.58), $0.20 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Baird Upgrades Titan Machinery (TITN) to Outperform
• Guming Holdings (1364:HK) PT Raised to HK$28 at JPMorgan
• Macquarie Downgrades Shanghai Chicmax Cosmetic (2145:HK) to Neutral